デフォルト表紙
市場調査レポート
商品コード
1413509

睡眠補助薬市場:製品別、睡眠障害別、流通チャネル別-2024-2030年の世界予測

Sleep Aids Market by Product (Mattresses & Pillows, Medications, Sleep Apnea Devices), Sleep-Disorder (Insomnia, Narcolepsy, Restless Legs Syndrome), Distribution Channel - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.94円
睡眠補助薬市場:製品別、睡眠障害別、流通チャネル別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

睡眠補助薬市場規模は2023年に593億2,000万米ドルと推計され、2024年には641億5,000万米ドルに達し、CAGR 5.98%で2030年には891億1,000万米ドルに達すると予測されます。

睡眠補助薬の世界市場

主な市場の統計
基準年[2023] 593億2,000万米ドル
予測年[2024] 641億5,000万米ドル
予測年 [2030] 891億1,000万米ドル
CAGR(%) 5.98%
睡眠補助薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは睡眠補助薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、睡眠補助薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-睡眠補助薬市場の市場規模および予測は?

2-睡眠補助薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-睡眠補助薬市場における技術動向と規制の枠組みは?

4-睡眠補助薬市場における主要ベンダーの市場シェアは?

5-睡眠補助薬市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • さまざまな形態の睡眠状態の治療と診断のニーズの増加
      • 睡眠障害に対する社会の意識の向上
      • ウェアラブルセンサーと追跡デバイスの受け入れが拡大
    • 抑制要因
      • 睡眠補助器具の不適切な校正
    • 機会
      • 睡眠補助薬における新技術のイントロダクション
      • 研究開発(R&D)への政府資金の増加により巨額の入札が可能睡眠補助薬
    • 課題
      • 許可ライセンスに必要な適切な書類が不足している
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 睡眠補助薬市場:製品別

  • マットレスと枕
    • 漢方薬
    • 一般用医薬品
    • 処方箋ベースの医薬品
  • 睡眠時無呼吸装置
    • 適応型サーボ人工呼吸器(ASV)
    • 顔のインターフェイス
    • 口腔器具
    • 気道陽圧(PAP)装置

第7章 睡眠補助薬市場睡眠障害別

  • 不眠症
  • ナルコレプシー
  • レストレスレッグス症候群
  • 睡眠時無呼吸
  • 睡眠歩行

第8章 睡眠補助薬市場:流通チャネル別

  • ドラッグストア
  • eコマース
  • 病院薬局
  • 小売薬局

第9章 南北アメリカの睡眠補助薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の睡眠補助薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの睡眠補助薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Apnea Sciences Corporation
    • Boehringer Ingelheim International GmbH
    • Cadwell Industries Inc.
    • Cleveland Medical Devices Inc.
    • Compumedics Limited
    • Drive DeVilbiss Healthcare Inc.
    • Eisai Co., Ltd.
    • Fisher & Paykel Healthcare Corp. Ltd.
    • Koninklijke Philips N. V.
    • Merck and Co. Inc.
    • Natus Medical Inc.
    • Nihon Kohden Corporation
    • Pfizer Inc.
    • ResMed Inc.
    • Sanofi S.A.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. SLEEP AIDS MARKET RESEARCH PROCESS
  • FIGURE 2. SLEEP AIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SLEEP AIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. SLEEP AIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SLEEP AIDS MARKET DYNAMICS
  • FIGURE 7. SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2030 (%)
  • FIGURE 10. SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. SLEEP AIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. SLEEP AIDS MARKET SIZE, BY MATTRESSES & PILLOWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SLEEP AIDS MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 9. SLEEP AIDS MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SLEEP AIDS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. SLEEP AIDS MARKET SIZE, BY PRESCRIPTION-BASED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 14. SLEEP AIDS MARKET SIZE, BY ADAPTIVE SERVO-VENTILATORS (ASVS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. SLEEP AIDS MARKET SIZE, BY FACIAL INTERFACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SLEEP AIDS MARKET SIZE, BY ORAL APPLIANCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. SLEEP AIDS MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 19. SLEEP AIDS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. SLEEP AIDS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. SLEEP AIDS MARKET SIZE, BY RESTLESS LEGS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. SLEEP AIDS MARKET SIZE, BY SLEEP WALKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. SLEEP AIDS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. SLEEP AIDS MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. SLEEP AIDS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. SLEEP AIDS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 239. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. SLEEP AIDS MARKET LICENSE & PRICING
目次
Product Code: MRR-AD517FAA7883

[188 Pages Report] The Sleep Aids Market size was estimated at USD 59.32 billion in 2023 and expected to reach USD 64.15 billion in 2024, at a CAGR 5.98% to reach USD 89.11 billion by 2030.

Global Sleep Aids Market

KEY MARKET STATISTICS
Base Year [2023] USD 59.32 billion
Estimated Year [2024] USD 64.15 billion
Forecast Year [2030] USD 89.11 billion
CAGR (%) 5.98%
Sleep Aids Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Sleep Aids Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Sleep Aids Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Sleep Aids Market, highlighting leading vendors and their innovative profiles. These include Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Industries Inc., Cleveland Medical Devices Inc., Compumedics Limited, Drive DeVilbiss Healthcare Inc., Eisai Co., Ltd., Fisher & Paykel Healthcare Corp. Ltd., Koninklijke Philips N. V., Merck and Co. Inc., Natus Medical Inc., Nihon Kohden Corporation, Pfizer Inc., ResMed Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Sleep Aids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Mattresses & Pillows
    • Medications
      • Herbal Drugs
      • OTC Drugs
      • Prescription-Based Drugs
    • Sleep Apnea Devices
      • Adaptive Servo-Ventilators (ASVs)
      • Facial Interfaces
      • Oral Appliances
      • Positive Airway Pressure (PAP) Devices
  • Sleep-Disorder
    • Insomnia
    • Narcolepsy
    • Restless Legs Syndrome
    • Sleep Apnea
    • Sleep Walking
  • Distribution Channel
    • Drug Stores
    • E-Commerce
    • Hospital Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Sleep Aids Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Sleep Aids Market?

3. What are the technology trends and regulatory frameworks in the Sleep Aids Market?

4. What is the market share of the leading vendors in the Sleep Aids Market?

5. Which modes and strategic moves are suitable for entering the Sleep Aids Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Sleep Aids Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for treating & diagnosing different forms of sleep conditions
      • 5.1.1.2. Rising public awareness of the sleep disorders
      • 5.1.1.3. Growing acceptance of wearable sensors and tracking devices
    • 5.1.2. Restraints
      • 5.1.2.1. Inappropriate calibration of devices of sleeping aids
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of novel technologies in sleeping aids
      • 5.1.3.2. Growing government funding for research & development (R&D) to bid huge sleep aids
    • 5.1.4. Challenges
      • 5.1.4.1. Absence of appropriate documents for the permitting license
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Sleep Aids Market, by Product

  • 6.1. Introduction
  • 6.2. Mattresses & Pillows
  • 6.3. Medications
    • 6.4.1. Herbal Drugs
    • 6.4.2. OTC Drugs
    • 6.4.3. Prescription-Based Drugs
  • 6.4. Sleep Apnea Devices
    • 6.5.1. Adaptive Servo-Ventilators (ASVs)
    • 6.5.2. Facial Interfaces
    • 6.5.3. Oral Appliances
    • 6.5.4. Positive Airway Pressure (PAP) Devices

7. Sleep Aids Market, by Sleep-Disorder

  • 7.1. Introduction
  • 7.2. Insomnia
  • 7.3. Narcolepsy
  • 7.4. Restless Legs Syndrome
  • 7.5. Sleep Apnea
  • 7.6. Sleep Walking

8. Sleep Aids Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. E-Commerce
  • 8.4. Hospital Pharmacies
  • 8.5. Retail Pharmacies

9. Americas Sleep Aids Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Sleep Aids Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Sleep Aids Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Apnea Sciences Corporation
    • 13.1.2. Boehringer Ingelheim International GmbH
    • 13.1.3. Cadwell Industries Inc.
    • 13.1.4. Cleveland Medical Devices Inc.
    • 13.1.5. Compumedics Limited
    • 13.1.6. Drive DeVilbiss Healthcare Inc.
    • 13.1.7. Eisai Co., Ltd.
    • 13.1.8. Fisher & Paykel Healthcare Corp. Ltd.
    • 13.1.9. Koninklijke Philips N. V.
    • 13.1.10. Merck and Co. Inc.
    • 13.1.11. Natus Medical Inc.
    • 13.1.12. Nihon Kohden Corporation
    • 13.1.13. Pfizer Inc.
    • 13.1.14. ResMed Inc.
    • 13.1.15. Sanofi S.A.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing